TargetMol

Fenoterol hydrochloride

Product Code:
 
TAR-T8358L
Product Group:
 
Inhibitors and Activators
Supplier:
 
TargetMol
Regulatory Status:
 
RUO
Shipping:
 
cool pack
Storage:
 
-20°C
1 / 1
❮❯

No additional charges, what you see is what you pay! *

CodeSizePrice
TAR-T8358L-100mg100mgEnquire
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T8358L-500mg500mgEnquire
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
Prices exclude any Taxes / VAT
How to order with us   Contact us
Stay in control of your spending. These prices have no additional charges, not even shipping!
* Rare exceptions are clearly labelled (only 0.14% of items!).
Multibuy discounts available! Contact us to find what you can save.
This product comes from: United States.
Typical lead time: 10-14 working days.
Contact us for more accurate information.
  • Further Information
  • Documents
  • References
  • Show All

Further Information

Bioactivity:
Fenoterol Hydrochloride is a β2-adrenergic agonist designed to open the airways to the lungs. It is a sympathetic β2-agonist and an asthma drug.
CAS:
01/10/1944
Molecular Weight:
339.82
Purity:
0.98
SMILES:
Cl.CC(Cc1ccc(O)cc1)NCC(O)c1cc(O)cc(O)c1

References

Bandaru S, Alvala M, Akka J, Sagurthi SR, Nayarisseri A, Singh SK, Mundluru HP. Identification of Small Molecule as a High Affinity ?2 Agonist Irrespectively Targeting Wild and Mutated (Thr164Ile) ? 2 Adrenergic Receptor in the Treatment of Bronchial Asthma. Curr Pharm Des. 2016 May 13. [Epub ahead of print] PubMed PMID: 27174812. Alves E, Lukoyanov N, Serr?o P, Moura D, Moreira-Rodrigues M. Epinephrine increases contextual learning through activation of peripheral ?2-adrenoceptors. Psychopharmacology (Berl). 2016 Jun;233(11):2099-108. doi: 10.1007/s00213-016-4254-5. Epub 2016 Mar 2. PubMed PMID: 26935825. Odnoshivkina YG, Sytchev VI, Petrov AM. Cholesterol regulates contractility and inotropic response to ?2-adrenoceptor agonist in the mouse atria: Involvement of G(i)-protein-Akt-NO-pathway. J Mol Cell Cardiol. 2016 May 8. pii: S0022-2828(16)30113-4. doi: 10.1016/j.yjmcc.2016.05.001. [Epub ahead of print] PubMed PMID: 27170493. Gory?ski K, Kiedrowicz A, Bojko B. Development of SPME-LC-MS method for screening of eight beta-blockers and bronchodilators in plasma and urine samples. J Pharm Biomed Anal. 2016 Aug 5;127:147-55. doi: 10.1016/j.jpba.2016.03.001. Epub 2016 Mar 4. PubMed PMID: 26971030.